Sanguiin H-6 blocks endothelial cell growth through inhibition of VEGF binding to VEGF receptor

Archives of Pharmacal Research

Volumn 28, Issue 11, 2005, Pages 1270-1274

  Lee, Sung Jin ^a   Lee, Hak Kyo ^a  

^a Hankyong National University   (South Korea)

Author keywords

Angiogenesis; Cancer; KDR Flk 1; VEGF

Indexed keywords

EID: 28844466431     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02978211     Document Type: Article

References (20)

1. Bae, D. G., Gho, Y. S., Yoon, W. H., and Chae, C. B., Argininerich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J. Biol. Chem., 275, 13588-13596 (2000).
2. Boehm-Viswanathan, T., Is angiogenesis inhibition the Holy Grail of cancer therapy? Curr. Opin. Oncol., 12, 89-94 (2000).
3. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A., Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435-439 (1996).
4. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W., Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-442 (1996).
5. Ferrara, N., VEGF and the quest for tumor angiogenesis factors. Nat. Rev. Cancer, 2, 795-803 (2002).
6. Folkman, J., What is the evidence that tumors are angiogenesis-dependent? J. Natl. Cancer Inst., 82, 4-6 (1991).
7. Gospodarowicz, D., Abraham, J. A., and Schilling, J., Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc. Natl. Acad. Sci. U.S.A., 86, 7311-7315 (1989).
8. Khatri, J.J., Johnson, C., Magid, R., Lessner, S. M., Laude, K. M., Dikalov, S. I., Harrison D.G., Sung H. J., Rong, Y., and Galis Z. S., Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation, 109, 520-525 (2004).
9. Kim, C. W., Lee, H. M., Lee, T. H., Kang, C., Kleinman, H. K., and Gho, Y. S., Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res., 62, 6312-6317 (2002a).
10. Kim, Y. M., Hwang, S., Kim, Y. M., Pyun, B. J., Kim, T. Y., Lee, S. T., Gho, Y. S., and Kwon, Y. G., Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J. Biol. Chem., 277, 27872-27879 (2002b).
11. Kondo, T., Ohta, T., Igura, K., Hara, Y., and Kaji, K., Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding. Cancer Lett., 180, 139-144 (2002).
12. Lamy, S., Gingras, D., and Beliveau, R., Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res., 62, 381-385 (2002).
13. Lee, S. J., Lee, H. M., Ji, S. T., Lee, S. R., Mar, W., and Gho, Y. S., 1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. Cancer Lett., 208, 89-94 (2004).
14. Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Frrarara, N., Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246, 1306-1309 (1989).
15. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A., High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846 (1993).
16. Ncosia, R. F., Tchao, R., and Leighton, J., Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res., 43, 2159-2166 (1983).
17. Nonaka, G. I., Tanaka, T., Nita, M., and Nishioka, I., A dimeric hydrolysable tannin, sanguiin H-6 from Sanguisorba officinalis L. Chem. Pharm. Bull., 30, 2255-2257 (1982).
18. Risau, W., Angiogenic growth factors. Prog. Growth Factor Res., 2, 71-79 (1990).
19. Shalaby, F., Rossant, J., Yamaguch, T. P., Gertsenstein, M., Wu, X.F., Breitman, M. L., and Schuh, S. C., Failure of blood-island formation vasculogenesis in Flk-1-deficient mice. Nature, 376 62-66 (1995).
20. Veikkola, T. and Alitalo, K., VEGFs, receptors and angiogenesis. Semin. Cancer Biol., 9, 211-220 (1999).